Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 739,805 |
| Open | 42.47 |
| Bid (Size) | 16.94 (200) |
| Ask (Size) | 59.50 (100) |
| Prev. Close | 42.18 |
| Today's Range | 41.88 - 43.15 |
| 52wk Range | 40.51 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
29.0% below 52-week high
42.38
40.5152W Low
59.6852W High
1 Week
5.7% below 1-week high
41.881W Low
44.931W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $40.51 and $59.68 over the past 52 weeks and last traded at $42.38, 29.0% below its 52-week high. Over the past week it ranged between $41.88 and $44.93.
Past 12 Months
1W
-$2.22
1M
-$1.15
3M
-$4.86
6M
-$8.16
YTD
-$7.09
1Y
-$5.93
SUPN was -12.3% over the past year, -16.1% over six months, -14.3% year to date, -5.0% in the last week.
12 Months vs Market
SUPN
-12.3%
DIA
+9.5%
SPY
+14.6%
QQQ
+23.3%
IWM
+14.1%
Over the past 12 months SUPN returned -12.3% versus DIA (Dow) +9.5%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +23.3% and IWM (Russell 2000) +14.1%.
Volume & Liquidity
0.95× 3-mo avg
Today 739,805
3-mo avg 778.4K
1W
626.6K
1M
647.1K
3M
778.4K
6M
747.4K
YTD
742.2K
1Y
764.4K
SUPN most recently traded 739,805 shares against a 3-month average daily volume of 778.4K.
More News
Read More
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
3 Russell 2000 Stocks We Approach with Caution
August 14, 2026
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
What's going on in today's pre-market session ↗
August 03, 2026
Supernus Announces Second Quarter 2026 Financial Results
August 03, 2026
Supernus Pharmaceuticals Earnings: What To Look For From SUPN
August 02, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 42.38
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.25B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.